BACKGROUND: Multiple familial trichoepithelioma type 1 (MFT1; MIM 601606), a rare monogenic skin disease with autosomal dominant inheritance, is characterized by the development of multiple skin-colored papules on the central area of the face, frequently occurring in the nasolabial area. The disease is associated with various mutations in the cylindromatosis (CYLD; MIM 605018) gene that are also responsible for familial cylindromatosis (FC) and Brooke-Spiegler syndrome (BSS). METHODS: Recently we have identified a Spanish MFT1 pedigree with two affected family members (father and daughter). Direct sequencing of the CYLD gene revealed a worldwide recurrent heterozygous nonsense mutation (c.2272C/T, p.R758X) in the patients. RESULTS: This mutation has already been detected in patients with all three clinical variants - BSS, FC and MFT1 - of the CYLD-mutation spectrum. Haplotype analysis was performed for the Spanish patients with MFT1, Dutch patients with FC and an Austrian patient with BSS, all of whom carry the same heterozygous nonsense p.R758X CYLD mutation. CONCLUSIONS: Our results indicate that this position is a mutational hotspot on the gene and that patients carrying the mutation exhibit high phenotypic diversity.

Department of Clinical Genetics Erasmus MC Rotterdam Netherlands

Department of Dermatology and Allergology University of Szeged Szeged Hungary

Department of Dermatology and Venereology of Consorcio Hospital Universitario de Valencia Valencia Spain

Department of Medical Genetics University of Szeged 4 Somogyi B H 6720 Szeged Hungary

Genetics Laboratory of Clinical Analysis Consorcio Hospital General Universitario de Valencia Valencia Spain

MTA SZTE Dermatological Research Group University of Szeged Szeged Hungary

The Sikl Department of Pathology Charles University Medical Faculty Hospital Medical Faculty in Pilsen Charles University Prague Pilsen Czech Republic

Unit of Molecular Genetics Bioptical Laboratory Pilsen Czech Republic

Zobrazit více v PubMed

Biggs PJ, Wooster R, Ford D, Chapman P, Mangion J, Quirk Y, et al. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat. Genet. 1995;11:441–443. doi: 10.1038/ng1295-441. PubMed DOI

Biggs PJ, Chapman P, Lakhani SR, Burn J, Stratton MR. The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas. Oncogene. 1996;12:1375–1377. PubMed

Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000;25:160–165. doi: 10.1038/76006. PubMed DOI

Fenske C, Banerjee P, Holden C, Carter N. Brooke-Spiegler syndrome locus assigned to 16q12-q13. J. Invest. Dermatol. 2000;114:1057–1058. doi: 10.1046/j.1523-1747.2000.00960.x. PubMed DOI

Gutierrez PP, Eggermann T, Holler D, Jugert FK, Beermann T, Grussendorf-Conen E-I, et al. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J. Invest. Dermatol. 2002;119:527–531. doi: 10.1046/j.1523-1747.2002.01839.x. PubMed DOI

Hu G, Onder M, Gill M, Aksakal B, Oztas M, Gurer MA, et al. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome. J. Invest. Dermatol. 2003;121:732–734. doi: 10.1046/j.1523-1747.2003.12514.x. PubMed DOI

Gerretsen AL, Beemer FA, Deenstra W, Hennekam FAM, van Vloten WA. Familial cutaneous cylindromas: investigations in five generations of a family. J. Am. Acad. Dermatol. 1995;33:199–206. doi: 10.1016/0190-9622(95)90234-1. PubMed DOI

Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NF-kappa-B signalling by deubiquitination. Nature. 2003;424:801–805. doi: 10.1038/nature01802. PubMed DOI

Van den Ouweland AM, Elfferich P, Lamping R, van de Graaf R, van Veghel-Plandsoen MM, Franken SM, et al. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis. Fam Cancer. 2011;10:127–132. doi: 10.1007/s10689-010-9393-y. PubMed DOI PMC

Grossmann P, Vanecek T, Steiner P, Kacerovska D, Spagnolo DV, Cribier B, et al. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens. Am J Dermatopathol. 2013;35:34–44. doi: 10.1097/DAD.0b013e31824e7658. PubMed DOI

Kazakov DV, Thoma-Uszynski S, Vanecek T, Kacerovska D, Grossmann P, Michal M. A case of Brooke-Spiegler syndrome with a novel germline deep intronic mutation in the CYLD gene leading to intronic exonization, diverse somatic mutations, and unusual histology. Am J Dermatopathol. 2009;31:664–673. doi: 10.1097/DAD.0b013e3181a05dad. PubMed DOI

Zhang G, Huang Y, Yan K, Li W, Fan X, Liang Y, et al. Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene. Exp Dermatol. 2006;15:966–970. doi: 10.1111/j.1600-0625.2006.00501.x. PubMed DOI

Oiso N, Mizuno N, Fukai K, Nakagawa K, Ishii M. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene. Br J Dermatol. 2004;151:1084–1086. doi: 10.1111/j.1365-2133.2004.06231.x. PubMed DOI

Kazakov DV, Vanecek T, Zelger B, Carlson JA, Spagnolo DV, Schaller J, et al. Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients. Am J Dermatopathol. 2011;33:251–265. doi: 10.1097/DAD.0b013e3181f7d373. PubMed DOI

Nagy N, Rajan N, Farkas K, Kinyó A, Kemény L, Széll M. A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds. Acta Derm Venereol. 2013;93:743–745. doi: 10.2340/00015555-1590. PubMed DOI PMC